Cyclophosphamide, epirubicin, and Fluorouracil versus dose-dense epirubicin and cyclophosphamide followed by Paclitaxel versus Doxorubicin and cyclophosphamide followed by Paclitaxel in node-positive or high-risk node-negative breast cancer (Q33561953)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Cyclophosphamide, epirubicin, and Fluorouracil versus dose-dense epirubicin and cyclophosphamide followed by Paclitaxel versus Doxorubicin and cyclophosphamide followed by Paclitaxel in node-positive or high-risk node-negative breast cancer |
scientific article |
Statements
1 reference
Cyclophosphamide, epirubicin, and Fluorouracil versus dose-dense epirubicin and cyclophosphamide followed by Paclitaxel versus Doxorubicin and cyclophosphamide followed by Paclitaxel in node-positive or high-risk node-negative breast cancer (English)
1 reference
Hope Rugo
1 reference
Edith A Perez
1 reference
Margot Burnell
1 reference
Mark N Levine
1 reference
Judith-Anne W Chapman
1 reference
Vivien Bramwell
1 reference
Karen Gelmon
1 reference
Barbara Walley
1 reference
Ted Vandenberg
1 reference
Haji Chalchal
1 reference
Kathy S Albain
1 reference
Patti O'Brien
1 reference
Lois E Shepherd
1 reference
9 November 2009
1 reference
1 reference
28
1 reference
77-82
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference